Related Experiment Video
Updated: Jul 9, 2026

An Efficient and Rapid HPLC-QQQ-MS Method for the Quantitation of Tropane Alkaloids in Medicinal Plants
Published on: June 12, 2026
Withanolides from Withania somnifera roots.
Laxminarain Misra1, Priyanka Mishra, Archana Pandey
1Central Institute of Medicinal and Aromatic Plants, P.O.-CIMAP, Lucknow 226015, India. laxmisra@hotmail.com
Researchers identified nine withanolides from Withania somnifera roots, including novel compounds with unique functional groups. This study expands the known chemical profile of this important medicinal plant.
Area of Science:
- Phytochemistry
- Natural Products Chemistry
- Medicinal Plant Research
Background:
- Withania somnifera (Ashwagandha) is a revered medicinal plant in traditional medicine.
- Its roots are known to contain bioactive compounds called withanolides.
- Further phytochemical investigation is crucial for understanding its therapeutic potential.
Purpose of the Study:
- To isolate and characterize novel and known withanolides from Withania somnifera roots.
- To identify compounds reported for the first time in the roots of this species.
- To elucidate the chemical structures of newly discovered withanolides.
Main Methods:
- Phytochemical analysis of Withania somnifera root extract.
- Isolation of compounds using chromatographic techniques.
- Structure elucidation via spectroscopic methods (e.g., NMR, MS) and chemical transformations.
Main Results:
- Isolation of two new and seven known withanolides.
- Identification of beta-sitosterol, stigmasterol, beta-sitosterol glucoside, stigmasterol glucoside, and alpha+beta glucose.
- First-time reporting of Viscosa lactone B, stigmasterol, stigmasterol glucoside, and alpha+beta glucose from Withania somnifera roots.
- Characterization of novel compounds with unique 16beta-acetoxy-17(20)-ene and 6alpha-hydroxy-5,7alpha-epoxy functionalities.
Conclusions:
- The phytochemical investigation successfully expanded the known chemical constituents of Withania somnifera roots.
- The discovery of novel withanolides with unique structural features warrants further investigation into their biological activities.
- This research contributes to the chemotaxonomic understanding and potential pharmaceutical applications of Withania somnifera.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...